OWP Pharmaceuticals has filed a notice of an exempt offering of securities to raise $2,730,773.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, OWP Pharmaceuticals is raising up to $2,730,773.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Steve Bourne played a…